AMBER MOHLMAN: Open Payments
NPI 1871289280 · MAITLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,297 in 128 payments from 23 companies in 2025. Trend: 2023 $216 · 2024 $1,725 · 2025 $3,297
Food & beverage: $3,202Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $429 |
| UCB, Inc. | 17 | $365 |
| Janssen Biotech, Inc. | 14 | $354 |
| Botanix SB Inc | 8 | $256 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $242 |
| LEO Pharma Inc. | 6 | $241 |
| Lilly USA, LLC | 5 | $203 |
| Novartis Pharmaceuticals Corporation | 11 | $197 |
| GENZYME CORPORATION | 3 | $164 |
| Regeneron Healthcare Solutions, Inc. | 5 | $117 |
Products named: Bimzelx, SKYRIZI, TREMFYA, DUPIXENT, SOFDRA, ILUMYA, ADBRY, ANZUPGO.
Industry payments across FL — which companies pay providers there.
